Colgate-Palmolive (CL) Shares Sold by Bontempo Ohly Capital Mgmt LLC
Bontempo Ohly Capital Mgmt LLC cut its stake in Colgate-Palmolive (NYSE:CL) by 0.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,550 shares of the company’s stock after selling 262 shares during the period. Colgate-Palmolive makes up approximately 1.6% of Bontempo Ohly Capital Mgmt LLC’s holdings, making the stock its 17th biggest position. Bontempo Ohly Capital Mgmt LLC’s holdings in Colgate-Palmolive were worth $2,042,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of CL. American Beacon Advisors Inc. bought a new stake in Colgate-Palmolive in the 1st quarter valued at $102,000. Proficio Capital Partners LLC lifted its holdings in shares of Colgate-Palmolive by 16.9% during the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after acquiring an additional 207 shares during the period. OLD Second National Bank of Aurora bought a new position in shares of Colgate-Palmolive during the 2nd quarter worth about $109,000. Harbour Capital Advisors LLC bought a new position in shares of Colgate-Palmolive during the 1st quarter worth about $121,000. Finally, Hanson & Doremus Investment Management lifted its holdings in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after acquiring an additional 70 shares during the period. 72.96% of the stock is owned by hedge funds and other institutional investors.
In other news, COO Justin Skala sold 126,393 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the completion of the sale, the chief operating officer now owns 262,361 shares in the company, valued at approximately $19,144,482.17. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CMO Mukul Deoras sold 7,500 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $73.28, for a total transaction of $549,600.00. Following the sale, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. Insiders sold a total of 173,673 shares of company stock valued at $12,629,293 in the last 90 days. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting the consensus estimate of $0.73. The firm had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.73 EPS. equities research analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.15%. The ex-dividend date was Friday, October 20th. Colgate-Palmolive’s payout ratio is presently 61.78%.
A number of equities analysts have recently commented on CL shares. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a report on Monday, September 25th. SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and raised their price objective for the stock from $65.00 to $85.00 in a report on Wednesday, October 11th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a report on Sunday, October 8th. Finally, Jefferies Group reaffirmed a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a report on Thursday, September 28th. Two equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the company’s stock. Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $76.04.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Stock Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related stocks with our FREE daily email newsletter.